Clinical Trials

NCT07137416 | RECRUITING | PHASE1
36 participants

Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-13
Start Date:
2026-10-05
Completion:
2028-01-10
Conditions
  • Anatomic Stage III Breast Cancer AJCC v8
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Invasive Breast Carcinoma
  • Locally Advanced Breast Carcinoma
  • Metastatic Breast Carcinoma
  • Metastatic HER2-Low Breast Carcinoma
  • Metastatic HER2-Positive Breast Carcinoma
  • Metastatic Hormone Receptor-Positive Breast Carcinoma
  • Metastatic Malignant Solid Neoplasm
  • Metastatic Triple-Negative Breast Carcinoma
  • Unresectable Breast Carcinoma
  • Unresectable HER2-Low Breast Carcinoma
  • Unresectable HER2-Positive Breast Carcinoma
  • Unresectable Hormone Receptor-Positive Breast Carcinoma
  • Unresectable Malignant Solid Neoplasm
  • Unresectable Triple-Negative Breast Carcinoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT07097558 | COMPLETED | NA
108 participants

Mandala and Music for PMS Relief

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-13
Start Date:
2025-08-13
Completion:
2026-03-31
Conditions
  • Mandala Coloring
  • Music Listening
  • Premenstrual Syndrome-PMS
Interventions
  • OTHER
No Results Yet
NCT07092566 | RECRUITING | PHASE3
170 participants

R.E.C.K vs Exparel in Robotic Nephrectomy

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-13
Start Date:
2025-11-14
Completion:
2027-10-31
Conditions
  • Renal Carcinoma
  • Nephrectomy / Methods
  • Pain Management
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page